FRM
TEVA icon

Fox Run Management’s Teva Pharmaceuticals TEVA Stock Holding History

Fox Run Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$218K Buy
+6,422
New +$214K 0.04% 790
2024
Q2 		– Sell
-43,333
Closed -$611K – 1074
2024
Q1 		$611K Sell
43,333
-3,263
-7% -$41.1K 0.13% 295
2023
Q4 		$486K Buy
+46,596
New +$435K 0.12% 307
2023
Q2 		– Sell
-41,299
Closed -$365K – 954
2023
Q1 		$365K Buy
+41,299
New +$408K 0.12% 341
2022
Q3 		– Sell
-23,001
Closed -$173K – 820
2022
Q2 		$173K Buy
+23,001
New +$200K 0.09% 428
2020
Q4 		– Sell
-10,646
Closed -$96K – 288
2020
Q3 		$96K Buy
+10,646
New +$113K 0.24% 146
2020
Q1 		– Sell
-30,174
Closed -$296K – 351
2019
Q4 		$296K Buy
+30,174
New +$269K 0.24% 204
2019
Q2 		– Sell
-16,205
Closed -$254K – 619
2019
Q1 		$254K Buy
16,205
+1,418
+10% +$25K 0.14% 320
2018
Q4 		$228K Buy
+14,787
New +$303K 0.12% 367
2018
Q3 		– Sell
-33,600
Closed -$817K – 816
2018
Q2 		$817K Buy
33,600
+22,784
+211% +$465K 0.26% 80
2018
Q1 		$185K Buy
+10,816
New +$211K 0.04% 643
2017
Q2 		– Sell
-27,500
Closed -$882K – 830
2017
Q1 		$882K Buy
+27,500
New +$938K 0.36% 40
2016
Q3 		– Sell
-4,400
Closed -$221K – 689
2016
Q2 		$221K Buy
+4,400
New +$234K 0.11% 399

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Fox Run Management's TEVA Position: Q2 2026 in Review

Fox Run Management opened a new position in Teva Pharmaceuticals (TEVA) in Q2 2026: 6,422 shares worth $218K. The stake represents 0.04% of the portfolio and ranks #790 among its holdings. This is a return to the name: Fox Run Management previously reported a position in TEVA as recently as Q1 2024.

Fox Run Management first reported a position in TEVA in Q2 2016 and has held it in 13 quarters since. The position peaked at $882K in Q1 2017. 674 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Fox Run Management held 6,422 shares of Teva Pharmaceuticals worth $218K as of Q2 2026.
  • Teva Pharmaceuticals was a new Fox Run Management position in Q2 2026.
  • Teva Pharmaceuticals made up 0.04% of Fox Run Management's portfolio in Q2 2026, its #790 holding.
  • Fox Run Management first reported a position in Teva Pharmaceuticals in Q2 2016 and has held it in 13 quarters since.
  • Fox Run Management's Teva Pharmaceuticals position peaked at $882K in Q1 2017.
  • 674 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Fox Run Management's 13F filing for Q2 2026, filed 4 Aug 2026.